Latest period
$34.05B
YoY change
-1.4%
5Y CAGR
-5.4%
Peak year (2017)
$27.92B
Latest annual
$15.07B
Total Debt history chart for Abbott Laboratories (ABT) from 1985 to 2025
Latest: $15.07B
Total Debt growth chart for Abbott Laboratories (ABT) from 1985 to 2025
Latest: -1.4%
Total Debt history table for Abbott Laboratories (ABT) from 1985 to 2025
| 2025 | $15.07B | -1.4% | −$208.00M | ||
| 2024 | $15.28B | -3.8% | −$598.00M | ||
| 2023 | $15.87B | -11.6% | −$2.07B | ||
| 2022 | $17.95B | -6.8% | −$1.30B | ||
| 2021 | $19.25B | -3.2% | −$639.00M | ||
| 2020 | $19.89B | +4.1% | +$791.00M | ||
| 2019 | $19.10B | -2.4% | −$467.00M | ||
| 2018 | $19.57B | -29.9% | −$8.36B | ||
| 2017 | $27.92B | +26.9% | +$5.92B | ||
| 2016 | $22.01B | +144.5% | +$13.01B | ||
| 2015 | $9.00B | +15.0% | +$1.17B | ||
| 2014 | $7.83B | +19.3% | +$1.27B | ||
| 2013 | $6.56B | -68.0% | −$13.91B | ||
| 2012 | $20.48B | +32.8% | +$5.06B | ||
| 2011 | $15.41B | -18.5% | −$3.50B | ||
| 2010 | $18.92B | +15.0% | +$2.46B | ||
| 2009 | $16.46B | +43.8% | +$5.01B | ||
| 2008 | $11.45B | -6.3% | −$768.40M | ||
| 2007 | $12.21B | -1.6% | −$197.22M | ||
| 2006 | $12.41B | +87.1% | +$5.78B | ||
| 2005 | $6.63B | -2.2% | −$147.10M | ||
| 2004 | $6.78B | +13.2% | +$790.93M | ||
| 2003 | $5.99B | -6.7% | −$432.94M | ||
| 2002 | $6.42B | -11.9% | −$866.20M | ||
| 2001 | $7.29B | +368.5% | +$5.73B | ||
| 2000 | $1.56B | -30.3% | −$677.24M | ||
| 1999 | $2.23B | -27.9% | −$865.71M | ||
| 1998 | $3.10B | +14.0% | +$379.44M | ||
| 1997 | $2.72B | +17.4% | +$402.71M | ||
| 1996 | $2.32B | +56.0% | +$831.56M | ||
| 1995 | $1.49B | +40.2% | +$425.47M | ||
| 1994 | $1.06B | -7.9% | −$90.84M | ||
| 1993 | $1.15B | +12.1% | +$124.13M | ||
| 1992 | $1.03B | +53.3% | +$356.90M | ||
| 1991 | $669.40M | -16.2% | −$129.20M | ||
| 1990 | $798.60M | +78.6% | +$351.40M | ||
| 1989 | $447.20M | -46.9% | −$395.40M | ||
| 1988 | $842.60M | -4.0% | −$34.80M | ||
| 1987 | $877.40M | -1.3% | −$11.70M | ||
| 1986 | $889.10M | +57.1% | +$323.20M | ||
| 1985 | $565.90M | — | — |
- 2025$15.07B-1.4%
- 2024$15.28B-3.8%
- 2023$15.87B-11.6%
- 2022$17.95B-6.8%
- 2021$19.25B-3.2%
- 2020$19.89B+4.1%
- 2019$19.10B-2.4%
- 2018$19.57B-29.9%
- 2017$27.92B+26.9%
- 2016$22.01B+144.5%
- 2015$9.00B+15.0%
- 2014$7.83B+19.3%
- 2013$6.56B-68.0%
- 2012$20.48B+32.8%
- 2011$15.41B-18.5%
- 2010$18.92B+15.0%
- 2009$16.46B+43.8%
- 2008$11.45B-6.3%
- 2007$12.21B-1.6%
- 2006$12.41B+87.1%
- 2005$6.63B-2.2%
- 2004$6.78B+13.2%
- 2003$5.99B-6.7%
- 2002$6.42B-11.9%
- 2001$7.29B+368.5%
- 2000$1.56B-30.3%
- 1999$2.23B-27.9%
- 1998$3.10B+14.0%
- 1997$2.72B+17.4%
- 1996$2.32B+56.0%
- 1995$1.49B+40.2%
- 1994$1.06B-7.9%
- 1993$1.15B+12.1%
- 1992$1.03B+53.3%
- 1991$669.40M-16.2%
- 1990$798.60M+78.6%
- 1989$447.20M-46.9%
- 1988$842.60M-4.0%
- 1987$877.40M-1.3%
- 1986$889.10M+57.1%
- 1985$565.90M—
Total Debt values are taken from Abbott Laboratories's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's latest reported total debt is $34.05B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Abbott Laboratories (ABT) total debt is $15.07B – edged down 1.4% year-over-year.
Abbott Laboratories total debt has contracted on net over the period, with a -5.4% compound annual growth rate over 2020–2025 (5 years).
The record annual total debt stands at $27.92B, reached in 2017; the historical low of $447.20M was recorded in 1989.
Abbott Laboratories Total Debt by Year
Abbott Laboratories Total Debt 2025: $15.07B
Abbott Laboratories total debt in 2025 was $15.07B, edged down 1.4% below 2024.
Abbott Laboratories Total Debt 2024: $15.28B
2024's total debt for Abbott Laboratories came in at $15.28B, edged down 3.8% below 2023.
Abbott Laboratories Total Debt 2023: $15.87B
Abbott Laboratories posted total debt of $15.87B in 2023, declined 11.6% below 2022.
Abbott Laboratories Total Debt 2022: $17.95B
In 2022, Abbott Laboratories reported total debt of $17.95B, declined 6.8% below 2021.
Abbott Laboratories Total Debt 2021: $19.25B
Abbott Laboratories total debt in 2021 was $19.25B.
See more financial history for Abbott Laboratories (ABT).
Sector peers by Total Debt
Healthcare peers of Abbott Laboratories (ABT), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $54.60B | |
| $50.53B | |
| $47.93B | |
| $42.50B | |
| $29.70B | |
| $20.59B |
- $78.39B
- $69.07B
- $54.60B
- $50.53B
- $47.93B
- $42.50B
- $29.70B
- $20.59B
Frequently asked questions
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation